Mangoceuticals (MGRX) FCF Margin (2023 - 2026)
Mangoceuticals' (MGRX) quarterly FCF Margin came in at 1932.31% in Q1 2026, up 14880.0% year-on-year from N/an in Q1 2025, and down 69.18% quarter-over-quarter from 1142.18% in Q4 2025.
Mangoceuticals (MGRX) FCF Margin (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed FCF Margin across 4 years of filings, most recently posting 1932.31% for Q1 2026.
- FCF Margin for Q1 2026 came in at 1932.31%, up 14880.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1178.74% (up 2408.0% YoY), and the FY2025 annual result was 1282.89%, down 49315.0% from the prior year.
- FCF Margin came in at 1932.31% for Q1 2026 at Mangoceuticals, down from 1142.18% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 462.94% in Q1 2024 to a low of 2081.11% in Q1 2025.
- The 4-year median for FCF Margin is 1073.26% (2024), against an average of 1169.65%.
- Across the five-year window, FCF Margin soared 133589 bps in 2024 and slumped 161817 bps in 2025, its largest moves.
- Mangoceuticals' FCF Margin stood at 694.73% in 2023, then slumped by 54 bps to 1073.26% in 2024, then slipped by 6 bps to 1142.18% in 2025, then slumped by 69 bps to 1932.31% in 2026.
- The last three FCF Margin figures came in at 1932.31% (Q1 2026), 1142.18% (Q4 2025), and 1473.38% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 127.46% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.30% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 23.01% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 23.62% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 17.24% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 73.79% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 22.17% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -8.19% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 13.57% |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | -1,932.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,932.31% |
| Dec 31, 2025 | -1,142.18% |
| Sep 30, 2025 | -1,473.38% |
| Jun 30, 2025 | -747.40% |
| Mar 31, 2025 | -2,081.11% |
| Dec 31, 2024 | -1,073.26% |
| Sep 30, 2024 | -874.15% |
| Jun 30, 2024 | -966.66% |
| Mar 31, 2024 | -462.94% |
| Dec 31, 2023 | -694.73% |
| Sep 30, 2023 | -697.81% |
| Jun 30, 2023 | -1,260.71% |
| Mar 31, 2023 | -1,798.83% |